Cyrille Lescop

Cyrille Lescop is an accomplished professional in the field of medicinal chemistry and project management, currently serving as Project Leader and Associate Director in preclinical project management at Idorsia Pharmaceuticals Ltd since June 2017, focusing on the design and synthesis of bioactive molecules for cardiovascular-fibrosis. Prior to this role, Cyrille held multiple positions at Actelion Pharmaceuticals Ltd from February 2007 to June 2017, including Principal Scientist and Senior Labhead, where responsibilities revolved around leading projects in cardiovascular-fibrosis and managing laboratories dedicated to immunologic disorders. Cyrille's career began at Santhera Pharmaceuticals from August 2002 to January 2007 as a Medicinal Chemist, contributing to the development of small molecules for neuromuscular and neurodegenerative disorders. Academic credentials include a Post-doctorate in Organic Chemistry from The University of Texas at Austin and a PhD from the University of Maine at LeMans, complemented by various degrees in chemistry.